Tel Aviv, Israel

Ety Klinger

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 1.3

ph-index = 7

Forward Citations = 144(Granted Patents)


Location History:

  • Tzahala, IL (2013 - 2014)
  • Tel Aviv, IL (2007 - 2016)

Company Filing History:


Years Active: 2007-2016

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Mind of Ety Klinger: Pioneering Multiple Sclerosis Treatment

Introduction: Ety Klinger, a prominent inventor based in Tel Aviv, Israel, has made significant contributions to medical science, especially in the treatment of multiple sclerosis (MS). With an impressive portfolio of 11 patents, Klinger is recognized for his innovative approaches to alleviating symptoms associated with this chronic disease, showcasing his commitment to improving patient care.

Latest Patents: Among Klinger’s latest inventions is a groundbreaking method known as low frequency glatiramer acetate therapy. This innovative treatment is designed to alleviate symptoms in patients with relapsing-remitting multiple sclerosis. The method involves administering three subcutaneous injections of a therapeutically effective dose of glatiramer acetate over a span of seven days, with at least one day between each injection. This systematic approach aims to provide relief to patients suffering from the debilitating effects of MS, particularly those at high risk of progressing to clinically definite multiple sclerosis.

Career Highlights: Klinger’s prolific career includes pivotal roles in noteworthy companies such as Teva Pharmaceutical Industries Limited and Yeda Research and Development Co. Ltd. His work at these organizations has allowed him to harness resources and collaborate with some of the brightest minds in the industry. Klinger’s dedication and expertise have positioned him as a leading figure in pharmaceutical innovation.

Collaborations: Throughout his career, Klinger has collaborated with talented individuals, including Shoshi Tessler and George Tachas. Their shared vision has facilitated advancements in treatment methodologies and has further enhanced Klinger’s impact within the medical research community.

Conclusion: Ety Klinger stands as a testament to the power of innovation in addressing complex health challenges. His relentless pursuit of effective treatments for multiple sclerosis, as evidenced by his patents and collaborations, marks a significant milestone in the quest for improved patient outcomes. As he continues to push the boundaries of medical science, Klinger inspires both current and future inventors in the field of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…